ASHLEE DAILEY: Open Payments
NPI 1679324149 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $90 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $33 |
| Neurelis, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| SANOFI PASTEUR INC. | 1 | $18 |
| BioMarin Pharmaceutical Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: BEXSERO, Qelbree, PREVNAR 20, VALTOCO, Wegovy, PEDIARIX, PENMENVY, ROTATEQ.
Industry payments across IA — which companies pay providers there.
